We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Initiating HIV antiretroviral therapy: Criteria, evidence, and controversy.
- Authors
Maldonado, Ana
- Abstract
The article focuses on the issues, evidence, and criteria related to the introduction of antiretroviral therapy for human immunodeficiency virus (HIV) in the U.S. The standard of care set by the Department of Health and Human Services (DHHS) presents the responsibility of physician assistants (PAs) on the use of antiretroviral (ARV) agents under evidence-based guidelines. DHHS recommends the time to initiate the therapy, which starts for patients with CD4 count of 350-500 cells/mm3.
- Subjects
ANTIVIRAL agents; BLOOD testing; BLOOD cell count; DRUG monitoring; ENZYME inhibitors; HIV infections; PHYSICIANS' assistants; T cells; TIME; EVIDENCE-based medicine; DECISION making in clinical medicine; PROTEASE inhibitors; VIRAL load; HIGHLY active antiretroviral therapy; CONTINUING education units; ATAZANAVIR; DARUNAVIR; EMTRICITABINE; RALTEGRAVIR; TENOFOVIR
- Publication
JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2011, Vol 24, Issue 2, p26
- ISSN
1547-1896
- Publication type
Article
- DOI
10.1097/01720610-201102000-00005